The Legend Holdings-backed aortic valve medical device developer has extended its series C by a further $10m after reaching a $62.5m first close last year.
Germany-based medical device maker JenaValve Technology has extended its series C round, which featured a unit owned by China-based investment holding company Legend Holdings, to $72.5m.
Legend Capital invested in the $62.5m first close of the series C in July 2013, along with Edmond de Rothschild Investment Partners, Atlas Venture Fund, NeoMed Management, VI Partners, Sunstone Capital, Gimv, and Omega Funds. The extra $10m was provided by Valiance Asset Management and RMM.
Founded in 2006, JenaValve produces transcatheter aortic valve…
